Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats.
about
The SphKs/S1P/S1PR1 axis in immunity and cancer: more ore to be minedRational modulation of the innate immune system for neuroprotection in ischemic strokeSphingolipids in spinal cord injuryFingolimod for the treatment of neurological diseases-state of play and future perspectivesFTY720 treatment in the convalescence period improves functional recovery and reduces reactive astrogliosis in photothrombotic strokeSphingosine-1-Phosphate Receptor-1 Selective Agonist Enhances Collateral Growth and Protects against Subsequent StrokeFTY720 reduces post-ischemic brain lymphocyte influx but does not improve outcome in permanent murine cerebral ischemiaFingolimod Limits Acute Aβ Neurotoxicity and Promotes Synaptic Versus Extrasynaptic NMDA Receptor Functionality in Hippocampal NeuronsInnate inflammatory responses in stroke: mechanisms and potential therapeutic targets.Isoflurane posttreatment reduces neonatal hypoxic-ischemic brain injury in rats by the sphingosine-1-phosphate/phosphatidylinositol-3-kinase/Akt pathway.Activation of immune responses to brain antigens after stroke.Mechanisms of osteopontin-induced stabilization of blood-brain barrier disruption after subarachnoid hemorrhage in ratsAntigen-specific immune reactions to ischemic stroke.MALDI-mass spectrometry imaging of desalted rat brain sections reveals ischemia-mediated changes of lipids.An update on sphingosine-1-phosphate and other sphingolipid mediators.Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activity.Treatment with the immunomodulator FTY720 does not promote spontaneous bacterial infections after experimental stroke in mice.Impact of an immune modulator fingolimod on acute ischemic stroke.Protective role of fingolimod (FTY720) in rats subjected to subarachnoid hemorrhage.S1P1 receptor modulation preserves vascular function in mesenteric and coronary arteries after CPB in the rat independent of depletion of lymphocytes.Changes in the metabolism of sphingolipids after subarachnoid hemorrhage.Sphingosine-1-phosphate signaling and its role in disease.Sphingolipids in cardiovascular diseases and metabolic disordersImportance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia.Artesunate Protected Blood-Brain Barrier via Sphingosine 1 Phosphate Receptor 1/Phosphatidylinositol 3 Kinase Pathway After Subarachnoid Hemorrhage in Rats.Ethanol triggers sphingosine 1-phosphate elevation along with neuroapoptosis in the developing mouse brain.The flavonoid fisetin attenuates postischemic immune cell infiltration, activation and infarct size after transient cerebral middle artery occlusion in miceJunctional protein regulation by sphingosine kinase 2 contributes to blood-brain barrier protection in hypoxic preconditioning-induced cerebral ischemic tolerance.The immunosuppressant FTY720 prolongs survival in a mouse model of diet-induced coronary atherosclerosis and myocardial infarction.Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier.Macrophage-Derived Angiopoietin-Like Protein 2 Exacerbates Brain Damage by Accelerating Acute Inflammation after Ischemia-ReperfusionFingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome.Exogenous S1P Exposure Potentiates Ischemic Stroke Damage That Is Reduced Possibly by Inhibiting S1P Receptor Signaling.Neuroprotective effects of adjunctive treatments for acute stroke thrombolysis: a review of clinical evidence.Influence of inflammation on poststroke plasticitySplenic immune cells in experimental neonatal hypoxia-ischemiaSphingolipids in cardiovascular and cerebrovascular systems: Pathological implications and potential therapeutic targets.Acute splenic irradiation reduces brain injury in the rat focal ischemic stroke model.Mechanism of Action and Clinical Potential of Fingolimod for the Treatment of Stroke.Role of the sphingosine metabolism pathway on neurons against experimental cerebral ischemia in rats
P2860
Q26748848-4CB0F7FA-03A9-450E-8FE3-0B8178D82181Q26851831-F48E4B84-29B5-4B80-86F6-7769E77603E5Q27026103-AD02C9A1-5230-4054-A020-2058E6CEE890Q27026175-2F91AC83-CFBE-443D-91C8-77F4FDADD9EEQ27310503-DC4D3CE9-09F9-4394-B42C-32CC472ECB78Q27317941-F77DCB31-4523-4592-ADB5-49A226C816F8Q28743446-51B22C69-7592-4732-BA3E-90785CB62DFEQ30836800-929C5DA7-AEED-4827-8A92-371E398FAD4DQ33925611-40DFBD2C-2633-4C62-AB1A-E8BF458D7601Q34049035-37DA71DC-DAB0-489F-B6F1-FB7BA1BC95CDQ34069139-F8A703B5-5166-4BED-8AF2-0973CA8EE3AEQ34073949-6359FE50-2037-475E-9220-C45B7A2115DAQ34171339-B5E0DFB2-9762-400E-BFAC-42CDFD58E8DBQ34275521-FC6A87C6-3E68-4766-91AD-83DC50DD07FFQ34402916-90D6B443-FE15-4E8F-A754-8C73BB8005BAQ34518822-01741E7F-A072-44D6-8E7D-17C47FC77213Q34743687-37C5BBCF-1509-470B-8AE3-AC58D048C156Q34792950-ED2E1613-BCFF-41A3-A324-8F69D60FE57DQ35074224-04943FFC-2E98-47B8-8B66-1424AF70693CQ35167202-A2B4B993-24AD-495C-A966-FE3C691CC1CDQ35175609-D8AD60CA-4FA5-46BF-86CC-FC1F2FE9D1A8Q35661485-0463402E-56AA-4624-931A-7AC65BF6E8C7Q35750931-470588DF-298C-4918-9C6B-BB099E11B8ACQ35866882-82E4460F-430C-463D-8DE2-9E6ED43D535CQ35907126-AB99A1AD-F6EB-4DB9-917C-3BDB84CDD069Q35928427-3C16CF05-EDAF-4188-AA7E-1576B0A933D4Q35939184-EA397342-EA8D-4ADE-B55A-24D9476C692BQ36008258-A2B5C65C-B1EC-4DDB-B0F7-5F85765EC1C9Q36072077-010E51FA-DF92-40F5-A85C-96DC6E09DAB1Q36181772-3C5FA190-E737-46AD-BDFB-74CF0E60029EQ36197228-BF0AFD20-C039-434C-AEB5-DA2E1763A0BAQ36212795-FA9D17CF-B61B-4C23-B7C3-D4DDC49497CFQ36241484-D54F93AF-F2F0-4786-ADD6-4D90E422DF2EQ36256704-FB29C5EC-ECCC-404D-9D22-3D5D9F9EE62CQ36679022-DEE9AED7-FF8C-4F47-8EBF-4B3E6717AEF9Q36786752-73CE57D4-8ABB-4D68-8839-36A0E78F4B92Q36840840-4F6BA238-04AE-48EC-9128-B793E1D6910CQ37095307-7FAF0D98-52F9-4FDD-9640-092DCACF188BQ37209163-81907D68-80C8-43B3-8B4A-6FFADDF218F8Q37265168-6A0623D5-136B-4D86-9EBD-479ED102A318
P2860
Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Activation of sphingosine 1-ph ...... after ischemic stroke in rats.
@ast
Activation of sphingosine 1-ph ...... after ischemic stroke in rats.
@en
type
label
Activation of sphingosine 1-ph ...... after ischemic stroke in rats.
@ast
Activation of sphingosine 1-ph ...... after ischemic stroke in rats.
@en
prefLabel
Activation of sphingosine 1-ph ...... after ischemic stroke in rats.
@ast
Activation of sphingosine 1-ph ...... after ischemic stroke in rats.
@en
P2093
P2860
P1433
P1476
Activation of sphingosine 1-ph ...... after ischemic stroke in rats
@en
P2093
Hidenori Suzuki
Takumi Sozen
William Rolland
Yu Hasegawa
P2860
P304
P356
10.1161/STROKEAHA.109.568899
P407
P577
2009-11-25T00:00:00Z